These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 29693876)

  • 1. The management of adnexal masses in premenopausal patients: a ten-year retrospective study at a single center.
    Ozcan HC; Balat O; Ugur MG; Kul S; Bozdag Z; Sucu S; Keklikcioglu I
    Eur J Gynaecol Oncol; 2017; 38(3):372-377. PubMed ID: 29693876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic accuracy and cost-effectiveness of different strategies to triage women with adnexal masses: a prospective study.
    Piovano E; Cavallero C; Fuso L; Viora E; Ferrero A; Gregori G; Grillo C; Macchi C; Mengozzi G; Mitidieri M; Pagano E; Zola P
    Ultrasound Obstet Gynecol; 2017 Sep; 50(3):395-403. PubMed ID: 27706929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The risk of malignancy index in discrimination of adnexal masses.
    Ulusoy S; Akbayir O; Numanoglu C; Ulusoy N; Odabas E; Gulkilik A
    Int J Gynaecol Obstet; 2007 Mar; 96(3):186-91. PubMed ID: 17280665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transvaginal color Doppler ultrasonography and CA-125 in suspicious adnexal masses.
    Alcázar JL; Errasti T; Zornoza A; Mínguez JA; Galán MJ
    Int J Gynaecol Obstet; 1999 Sep; 66(3):255-61. PubMed ID: 10580673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative multimodal strategies for risk assessment of adnexal masses: analysis of 1362 cases in a gynecologic cancer center.
    Radosa MP; Camara O; Vorwergk J; Diebolder H; Winzer H; Mothes A; Gajda M; Runnebaum IB
    Int J Gynecol Cancer; 2011 Aug; 21(6):1056-62. PubMed ID: 21633301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adding cancer antigen 125 screening to gray scale sonography for predicting specific diagnosis of benign adnexal masses in premenopausal women: is it worthwhile?
    Alcázar JL; Guerriero S; Mínguez JÁ; Ajossa S; Paoletti AM; Ruiz-Zambrana A; Jurado M
    J Ultrasound Med; 2011 Oct; 30(10):1381-6. PubMed ID: 21968488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The contribution of laparoscopy to the diagnosis of adnexal masses in young and premenopausal women.
    Liberis V; Tsikouras P; Zografos Ch; Ammari A; Dislian V; Iatrou Ch; Maroulis G
    Eur J Gynaecol Oncol; 2009; 30(4):402-7. PubMed ID: 19761131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. External validation of the adapted Risk of Malignancy Index incorporating tumor size in the preoperative evaluation of adnexal masses.
    van den Akker PA; Zusterzeel PL; Aalders AL; Snijders MP; Samlal RA; Vollebergh JH; Kluivers KB; Massuger LF
    Eur J Obstet Gynecol Reprod Biol; 2011 Dec; 159(2):422-5. PubMed ID: 21824712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of a risk of malignancy index in clinical approaches to adnexal masses.
    Simsek HS; Tokmak A; Ozgu E; Doganay M; Danisman N; Erkaya S; Gungor T
    Asian Pac J Cancer Prev; 2014; 15(18):7793-7. PubMed ID: 25292065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discrimination between benign and malignant adnexal masses by specialist ultrasound examination versus serum CA-125.
    Van Calster B; Timmerman D; Bourne T; Testa AC; Van Holsbeke C; Domali E; Jurkovic D; Neven P; Van Huffel S; Valentin L
    J Natl Cancer Inst; 2007 Nov; 99(22):1706-14. PubMed ID: 18000221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Application values of four risk of malignancy indices in the preoperative evaluation of patients with adnexal masses].
    Lou HY; Meng H; Zhu QL; Zhang Q; Jiang YX
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2010 Jun; 32(3):297-302. PubMed ID: 20602883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of ultrasound features and the Risk of Ovarian Malignancy Algorithm score for different histopathological subtypes of benign adnexal masses.
    Ionescu CA; Matei A; Navolan D; Dimitriu M; Bohâltea R; Neacsu A; Ilinca C; Ples L
    Medicine (Baltimore); 2018 Aug; 97(31):e11762. PubMed ID: 30075600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selected adnexal cystic masses in postmenopausal women can be safely managed by laparoscopy.
    Lee JW; Kim CJ; Lee JE; Lee SJ; Kim BG; Lee JH; Bae DS; Park CS
    J Korean Med Sci; 2005 Jun; 20(3):468-72. PubMed ID: 15953871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human epididymis protein 4 offers superior specificity in the differentiation of benign and malignant adnexal masses in premenopausal women.
    Holcomb K; Vucetic Z; Miller MC; Knapp RC
    Am J Obstet Gynecol; 2011 Oct; 205(4):358.e1-6. PubMed ID: 21722869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Multiparametric MRI (mMRI) on the Therapeutic Management of Adnexal Masses Detected with Transvaginal Ultrasound (TVUS): An Interdisciplinary Management Approach.
    Dirrichs T; Bauerschlag D; Maass N; Kuhl CK; Schrading S
    Acad Radiol; 2022 Feb; 29(2):183-197. PubMed ID: 33293256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective external validation of IOTA three-step strategy for characterizing and classifying adnexal masses and retrospective assessment of alternative two-step strategy using simple-rules risk.
    Hidalgo JJ; Ros F; Aubá M; Errasti T; Olartecoechea B; Ruiz-Zambrana Á; Alcázar JL
    Ultrasound Obstet Gynecol; 2019 May; 53(5):693-700. PubMed ID: 30353585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multicenter study of laparoscopic management of selected cystic adnexal masses in postmenopausal women.
    Parker WH; Levine RL; Howard FM; Sansone B; Berek JS
    J Am Coll Surg; 1994 Dec; 179(6):733-7. PubMed ID: 7952486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of malignancy index in the preoperative evaluation of patients with adnexal masses.
    Andersen ES; Knudsen A; Rix P; Johansen B
    Gynecol Oncol; 2003 Jul; 90(1):109-12. PubMed ID: 12821350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective study to evaluate the risk malignancy index and its diagnostic implication in patients with suspected ovarian mass.
    Dora SK; Dandapat AB; Pande B; Hota JP
    J Ovarian Res; 2017 Aug; 10(1):55. PubMed ID: 28806987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the importance of the serum levels of CA-125, CA15-3, CA-19-9, carcinoembryonic antigen and alpha fetoprotein for distinguishing benign and malignant adnexal masses and contribution of different test combinations to diagnostic accuracy.
    Bozkurt M; Yumru AE; Aral I
    Eur J Gynaecol Oncol; 2013; 34(6):540-4. PubMed ID: 24601047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.